OBESITY and DYSLIPIDEMIA: a review of current evidence OBESITY and DYSLIPIDEMIA OBESITY and DYSLIPIDEMIA DYSLIPIDEMIA in OBESITY: mechanisms and potential targets OBESITY and DYSLIPIDEMIA OBESITY and DYSLIPIDEMIA OBESITY and DYSLIPIDEMIA Risk of DYSLIPIDEMIA in obese young adult subjects as measured by various OBESITY indices Tackling DYSLIPIDEMIA in OBESITY from a nanotechnology perspective Lipid profile and the frequency of DYSLIPIDEMIA in Iranian adolescents with severe OBESITY, who were candidates for bariatric surgery Consumption of Green Tea As Anti-DYSLIPIDEMIA Agent and OBESITY Prevention: A Systematic Review Lifestyle Intervention in Reducing Cardiometabolic Risk Factors in Students with DYSLIPIDEMIA and Abdominal OBESITY: A Randomized Study DYSLIPIDEMIA and pediatric OBESITY DYSLIPIDEMIA, OBESITY, and ethnicity in Mexican children OBESITY and DYSLIPIDEMIA in early life: Impact on cardiometabolic risk OBESITY and DYSLIPIDEMIA in South Asians OBESITY and DYSLIPIDEMIA in Chinese adults: a cross-sectional study in Shanghai, China DYSLIPIDEMIA and abdominal OBESITY: an assessment in three general populations OBESITY and atherogenic DYSLIPIDEMIA Association of OBESITY with hypertension and DYSLIPIDEMIA in type 2 diabetes mellitus subjects Associations of OBESITY and DYSLIPIDEMIA with intake of sodium, fat, and sugar among Koreans: a qualitative systematic review DYSLIPIDEMIA, OBESITY and other cardiovascular risk factors in the adult population in Senegal DYSLIPIDEMIA of central OBESITY and insulin resistance OBESITY and DYSLIPIDEMIA. The association of DYSLIPIDEMIA and OBESITY with glycated hemoglobin OBESITY, adiposity, and DYSLIPIDEMIA: a consensus statement from the National Lipid Association A Holistic View of Psoriasis: Examining Its Association With DYSLIPIDEMIA and OBESITY in a Decade-Long Systematic Review and Meta-Analysis The effects of antioxidants from natural products on OBESITY, DYSLIPIDEMIA, diabetes and their molecular signaling mechanism OBESITY, hypertension, and DYSLIPIDEMIA in childhood are key modifiable antecedents of adult cardiovascular disease: a call to action DYSLIPIDEMIA in visceral OBESITY: mechanisms, implications, and therapy Association of anthropometric variables with DYSLIPIDEMIA in OBESITY OBESITY and its metabolic complications: the role of adipokines and the relationship between OBESITY, inflammation, insulin resistance, DYSLIPIDEMIA and … Association of general and abdominal OBESITY with hypertension, DYSLIPIDEMIA and prediabetes in the PREDAPS Study Approach to identifying and managing atherogenic DYSLIPIDEMIA: a metabolic consequence of OBESITY and diabetes Prevalence of OBESITY, high blood pressure, DYSLIPIDEMIA and their associated factors in children and adolescents in a municipality in the Brazilian Amazon … OBESITY and risk for its comorbidities diabetes, hypertension, and DYSLIPIDEMIA in Japanese individuals aged 65 years The impact of stress systems and lifestyle on DYSLIPIDEMIA and OBESITY in anxiety and depression Effects of vitamin D supplementation on fasting glucose, DYSLIPIDEMIA, blood pressure, and abdominal OBESITY among patients with metabolic syndrome: a … Association of central type of OBESITY and hypertension in patients with DYSLIPIDEMIA OBESITY, DYSLIPIDEMIA, and high blood pressure are associated with cardiovascular risk, determined using high-sensitivity C-reactive protein concentration, in young … DYSLIPIDEMIA Incidents Between General OBESITY and Central OBESITY of Employees with OBESITY at Universitas Lampung Insulin resistance: a multifaceted syndrome responsible for NIDDM, OBESITY, hypertension, DYSLIPIDEMIA, and atherosclerotic cardiovascular disease Drugs involved in DYSLIPIDEMIA and OBESITY treatment: focus on adipose tissue The prevalence of overweight/OBESITY and DYSLIPIDEMIA amongst a group
The central MELANOCORTIN system as a treatment target for OBESITY and diabetes: A brief overview OBESITY and Stress: The MELANOCORTIN Connection Loss‐of‐function mutations in the MELANOCORTIN‐3 receptor gene confer risk for human OBESITY: A systematic review and meta‐analysis A unique metalolic sysdrone causes OBESITY in the MELANOCORTIN-3 receptor-deficient mouse The MELANOCORTIN-4 receptor as target for OBESITY treatment: a systematic review of emerging pharmacological therapeutic options The MELANOCORTIN pathway and energy homeostasis: From discovery to OBESITY therapy Clinical spectrum of OBESITY and mutations in the MELANOCORTIN 4 receptor gene The central MELANOCORTIN system and human OBESITY OBESITY in the mouse model of pro-opioMELANOCORTIN deficiency responds to peripheral MELANOCORTIN MELANOCORTIN-4 receptor in energy homeostasis and OBESITY pathogenesis MELANOCORTIN-4 receptor signalling: importance for weight regulation and OBESITY treatment Pro-opioMELANOCORTIN processing in the hypothalamus: impact on MELANOCORTIN signalling and OBESITY Targeted disruption of the MELANOCORTIN-4 receptor results in OBESITY in mice Neural MELANOCORTIN receptors in OBESITY and related metabolic disorders MELANOCORTIN signalling and the regulation of blood pressure in human OBESITY The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced MELANOCORTIN OBESITY and the contribution of hypothalamic … MELANOCORTIN‐4 receptor complexity in energy homeostasis, OBESITY and drug development strategies MELANOCORTIN-4 receptor mutations are a frequent and heterogeneous cause of morbid OBESITY Dominant and recessive inheritance of morbid OBESITY associated with MELANOCORTIN 4 receptor deficiency Effect of interactions of polymorphisms in the MELANOCORTIN‐4 receptor gene with dietary factors on the risk of OBESITY and Type 2 diabetes: a systematic review The MELANOCORTIN‐4 receptor pathway and the emergence of precision medicine in OBESITY management A metabolic defect promotes OBESITY in mice lacking MELANOCORTIN-4 receptors MELANOCORTIN-4 receptor gene variant I103 is negatively associated with OBESITY Mutations in ligands and receptors of the leptin–MELANOCORTIN pathway that lead to OBESITY OBESITY-Associated GNAS Mutations and the MELANOCORTIN Pathway Mutations in MELANOCORTIN‐4 receptor and human OBESITY MELANOCORTIN receptor accessory proteins in adrenal disease and OBESITY MELANOCORTIN‐4 receptor mutations in OBESITY Molecular mechanisms of the neural MELANOCORTIN receptor dysfunction in severe early onset OBESITY Effects of acute and chronic administration of the MELANOCORTIN agonist MTII in mice with diet-induced OBESITY Understanding MELANOCORTIN-4 receptor control of neuronal circuits: toward novel therapeutics for OBESITY syndrome OBESITY-associated mutations in the MELANOCORTIN 4 receptor provide novel insights into its function Synaptic input organization of the MELANOCORTIN system predicts diet-induced hypothalamic reactive gliosis and OBESITY Functional characterization of MELANOCORTIN-4 receptor mutations associated with childhood OBESITY OBESITY treatment effect in Danish children and adolescents carrying MELANOCORTIN-4 Receptor mutations Loss of function of the MELANOCORTIN 2 receptor accessory protein 2 is associated with mammalian OBESITY The role of MELANOCORTIN 3 receptor gene in childhood OBESITY A Novel MELANOCORTIN 3 Receptor Gene (MC3R) Mutation Associated with Severe OBESITY Diet-induced OBESITY causes severe but reversible leptin resistance in arcuate MELANOCORTIN neurons MELANOCORTIN-4 receptor–deficient mice are not hypertensive or salt-sensitive despite OBESITY, hyperinsulinemia, and hyperleptinemia Effect of setmelanotide, a MELANOCORTIN‐4 receptor agonist, on OBESITY in Bardet‐Biedl syndrome Gain‐of‐function variants in the MELANOCORTIN 4 receptor gene confer susceptibility to binge eating
PPARα and dyslipidemia The role of PPARα in lipid metabolism and obesity: focusing on the effects of estrogen on PPARα actions PPARα in atherosclerosis and inflammation Sorting out the roles of PPARα in energy metabolism and vascular homeostasis PPARα: energy combustion, hypolipidemia, inflammation and cancer Comparative analysis of gene regulation by the transcription factor PPARα between mouse and human The PPARα–leukotriene B4 pathway to inflammation control PPARα is a key regulator of hepatic FGF21 PPARα governs glycerol metabolism The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus Identification of a physiologically relevant endogenous ligand for PPARα in liver PPARα gene variation and physical performance in Russian athletes PPARα: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators The PPARα-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPARα A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation … trans-Activation of PPARα and Induction of PPARα Target Genes by Perfluorooctane-Based Chemicals Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21 Activation of PPARα and PPARγ by environmental phthalate monoesters Molecular scanning of the human PPARα gene: association of the L162V mutation with hyperapobetalipoproteinemia trans-Activation of PPARα and PPARγ by structurally diverse environmental chemicals Cannabinoid activation of PPARα; a novel neuroprotective mechanism Etomoxir-induced PPARα-modulated enzymes protect during acute renal failure Role of PPARα in hepatic carbohydrate metabolism Genome-wide analysis of PPARα activation in murine small intestine PPARα is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue Association between the PPARα-L162V polymorphism and components of the metabolic syndrome Effect of endurance training on lipid metabolism in women: a potential role for PPARα in the metabolic response to training Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators PPARα activator effects on Ang II–induced vascular oxidative stress and inflammation “New” hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARα Gene expression profiling in wild-type and PPARα-null mice exposed to perfluorooctane sulfonate reveals PPARα-independent effects Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol … Characterization of the human PPARα promoter: identification of a functional nuclear receptor response element Cannabinoids and PPARα signalling PPARα: an emerging therapeutic target in diabetic microvascular damage PPARα agonist-induced rodent tumors: modes of action and human relevance Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice Role of PPARα in mediating the effects of phthalates and metabolites in the liver Fibrates and future PPARα agonists in the treatment of cardiovascular disease PPARα in the pathogenesis of fatty liver disease Stimulation of PPARα promotes epidermal keratinocyte differentiation in vivo Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner Amelioration of high fructose-induced metabolic derangements by activation of PPARα Peroxisome proliferator-activated receptor-alpha (PPARα): at the crossroads of
Sphingolipids in food and the emerging importance of Sphingolipids to nutrition Functions of Sphingolipids and Sphingolipid breakdown products in cellular regulation Sphingolipid metabolism and cell growth regulation Sphingolipids—the enigmatic lipid class: biochemistry, physiology, and pathophysiology Sphingolipids Yeast Sphingolipids Sphingolipids with inositolphosphate-containing head groups. Phases and phase transitions of the Sphingolipids The role of Sphingolipids in the process of signal transduction Sphingolipids—their metabolic pathways and the pathobiochemistry of neurodegenerative diseases Sphingolipid long chain bases Sphingolipids in atherosclerosis and vascular biology Molecular arrangements in Sphingolipids. The crystal structure of cerebroside Sphingolipid organization in biomembranes: what physical studies of model membranes reveal Importance of Sphingolipids and inhibitors of Sphingolipid metabolism as components of animal diets Sphingolipids Are Potential Heat Stress Signals inSaccharomyces Sphingolipid FUNCTIONS IN SACCHAROMYCES CEREVISIAE: Comparison to Mammals Khafrefungin, a novel inhibitor of Sphingolipid synthesis Sphingolipid transport in eukaryotic cells Structure and function of Sphingolipid-and cholesterol-rich membrane rafts Sorting of Sphingolipids in epithelial (Madin-Darby canine kidney) cells. Involvement of yeast Sphingolipids in the heat stress response of Saccharomyces cerevisiae Metabolism and functional effects of Sphingolipids in blood cells Biosynthesis of Sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells Different Sphingolipids show differential partitioning into Sphingolipid/cholesterol-rich domains in lipid bilayers Role of Sphingolipid-mediated cell death in neurodegenerative diseases Sphingolipids are required for mammalian epidermal barrier function. Inhibition of Sphingolipid synthesis delays barrier recovery after acute perturbation. Caveolae, DIGs, and the dynamics of Sphingolipid—cholesterol microdomains Inhibition of Sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme Viridiofungins, novel inhibitors of Sphingolipid synthesis Uptake and metabolism of Sphingolipids in isolated intestinal loops of mice Methods for methanolysis of Sphingolipids and direct determination of long‐chain bases by gas chromatography The phosphoinositol Sphingolipids of Saccharomyces cerevisiae are highly localized in the plasma membrane Regulation of epidermal Sphingolipid synthesis by permeability barrier function. Lipid biochemistry: functions of glycerolipids and Sphingolipids in cellular signaling Sphingolipids Improved reagent for trimethylsilylation of Sphingolipid bases A regulatory role for Sphingolipids in neuronal growth: inhibition of Sphingolipid synthesis and degradation have opposite effects on axonal branching Cell regulation by sphingosine and more complex Sphingolipids Sphingolipids: metabolism and cell signalling Sphingolipids as receptor modulators: an overview Variations among cell lines in the synthesis of Sphingolipids in de novo and recycling pathways Interaction of influenza virus haemagglutinin with Sphingolipid–cholesterol membrane domains via its transmembrane domain Effects of cholesterol depletion by cyclodextrin on the Sphingolipid microdomains of the plasma membrane Activator proteins and topology of lysosomal Sphingolipid catabolism Biochemical studies in Niemann-Pick disease I. Major Sphingolipids of liver and spleen Sphingolipid composition in Bacteroides species ELO2 and ELO3, Homologues of theSaccharomyces cerevisiae ELO1 Gene, Function in Fatty Acid Elongation and Are Required for Sphingolipid Formation Qualitative microanalysis and estimation of Sphingolipid bases Molecular arrangements in Sphingolipids Conformation and hydrogen bonding of ceramide and their implication on membrane stability and permeability Molecular arrangements in Sphingolipids. Crystal structure of N-tetracosanoylphytosphingosine Role of dietary Sphingolipids and inhibitors of Sphingolipid metabolism in cancer and other diseases Effect of essential fatty acid deficiency on the epidermal
Exercise training prevents obesity-associated disorders: Role of miRNA-208a and MED13 Regular physical Exercise: way to healthy life. Prevention and treatment of obesity-an over view Provision of a voluntary Exercise environment enhances running activity and prevents obesity in Snark-deficient mice Resistance training prevents the cardiovascular changes caused by high-fat diet Maternal low intensity physical Exercise prevents obesity in offspring rats exposed to early overnutrition Lack of Exercise is a major cause of chronic diseases Anthropometrical parameters and markers of obesity in rats Exercise Training prevents obesity Normalizing Cardiac Mirna-208a and Med13 Levels in Obese Zucker Rats Exercise and Diet-Induced obesity in Mice EFFECTS OF NORDIC WALKING ON GLYCEMIC CONTROL AND FUNCTIONAL CAPACITY IN OLDER WOMEN WITH TYPE 2 DIABETES MELLITUS. DATA … The effects of the parent training program for obesity reduction on anthropometric measures of school-age children Dihydromyricetin prevents obesity-induced slow-twitch-fiber reduction partially via FLCN/FNIP1/AMPK pathway Physical activity levels among the general US adult population and in adults with and without arthritis Effects of voluntary running on oxygen consumption, RQ, and energy expenditure during primary prevention of diet-induced obesity in C57BL/6N mice Effect of Vigorous aerobic Exercise on Serum Levels of SIRT1, FGF21 and Fetuin A in Women with Type II Diabetes. Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with 'Exercise mimetics' Effect of 8-week Zumba training on overweight women's body composition. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work The role of Exercise in weight maintenance Daily physical activity enhances reactivity to insulin in skeletal muscle arterioles of hyperphagic Otsuka Long-Evans Tokushima Fatty rats Astaxanthin improves muscle lipid metabolism in Exercise via inhibitory effect of oxidative CPT I modification Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice Regular Exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism The effect of Exercise on skeletal muscle fibre type distribution in obesity: From cellular levels to clinical application aerobic Exercise training–induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin II, and … Does physical activity enhance health? The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to Exercise training and diet in obesity aerobic Exercise training promotes physiological cardiac remodeling involving a set of microRNAs Moderate Exercise restores pancreatic beta-cell function and autonomic nervous system activity in obese rats induced by high-fat diet Maternal Exercise improves the metabolic health of adult offspring Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity Mechanisms of protective action of physical activity on the occurrence, clinical course, and functional recovery from ischemic stroke Oxidative stress and obesity Selected body composition fractions in relation to the Physical Activity in overweight and obese women aged 30–45 years Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice Responses of Muscle Mitochondrial Function to Physical Activity: A Literature Review. Exercise, Frailty,
Exercise has anti aging effects via: 1. Improved Mitochondrial Function: Exercise has been shown to improve mitochondrial function in skeletal muscle. Mitochondria are responsible for producing energy in cells, and their dysfunction is associated with aging. Exercise can increase the number and efficiency of mitochondria, leading to improved energy production and overall muscle function. 2. Increased Muscle Strength: Resistance exercise training can increase muscle strength in older adults. This improvement in strength is not only due to muscle hypertrophy (increase in muscle size) but also to improvements in neuromuscular coordination and activation. These adaptations can help reverse the age-related decline in muscle strength. 3. Enhanced Protein Synthesis: Exercise stimulates protein synthesis in skeletal muscle, leading to the production of new muscle proteins. This is important for muscle growth, repair, and maintenance. Aging is associated with a decline in protein synthesis, and exercise can help counteract this decline by promoting protein turnover and muscle protein synthesis. 4. Reduced Oxidative Stress: Aging is associated with increased oxidative stress, which can damage cells and contribute to muscle dysfunction. Exercise has been shown to reduce oxidative stress by increasing antioxidant enzyme activity and reducing markers of oxidative damage. This can help protect muscle cells from oxidative damage and improve overall muscle health. 5. Improved Gene Expression: Exercise can modulate gene expression in skeletal muscle, leading to changes in the expression of genes involved in muscle growth, metabolism, and inflammation. These changes in gene expression can help reverse the age-related alterations in the transcriptome profile of skeletal muscle, leading to a more youthful gene expression profile Resistance exercise reverses aging in human skeletal muscle Aerobic exercise reverses arterial inflammation with aging in mice Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids exercise reverses ethanol inhibition of neural stem cell proliferation exercise reverses metabolic syndrome in high-fat diet-induced obese rats. exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brain-derived neurotrophic factor Low-intensity exercise reverses chronic muscle pain in the rat in a naloxone-dependent manner Acute exercise reverses aged-induced impairments in insulin signaling in rodent skeletal muscle Intervention with education and exercise reverses the metabolic syndrome in adults exercise reverses chronic stress-induced Bax oligomer formation in the cerebral cortex exercise reverses Peripheral Insulin Resistance in Trained L-NAME–Hypertensive Rats exercise reverses preamyloid oligomer and prolongs survival in αB-crystallin-based desmin-related cardiomyopathy Acute physical exercise reverses S‐nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet‐induced obese Wistar rats exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle Melatonin administrated immediately before an intense exercise reverses oxidative stress, improves immunological defenses and lipid metabolism in football players exercise reverses depressed metabolic rate produced by severe caloric restriction. Physical exercise reverses glutamate uptake and oxidative stress effects of chronic homocysteine administration in the rat Acute exercise reverses TRB3 expression in the skeletal muscle and ameliorates whole body
The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised … obesity and nonalcoholic fatty liver disease Abdominal obesity and fatty liver obesity and nonalcoholic fatty liver disease: current perspectives obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications fatty liver disease in morbid obesity Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations obesity, fatty liver and liver cancer. obesity is an independent risk factor for non‐alcoholic fatty liver disease: evidence from a meta‐analysis of 21 cohort studies liver cancer: connections with obesity, fatty liver, and cirrhosis Non-alcoholic fatty liver disease, obesity and the metabolic syndrome Efficacy of dietary intervention and physical activity in children and adolescents with nonalcoholic fatty liver disease associated with obesity: A scoping review Prevalence of nonalcoholic fatty liver disease in children with obesity obesity and the liver: nonalcoholic fatty liver disease Prevalence of fatty liver in Japanese children and relationship to obesity: an epidemiological ultrasonographic survey Nonalcoholic fatty liver disease and obesity treatment Alcohol and obesity: a dangerous association for fatty liver disease The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer … impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: the fatty liver in obesity (FLiO) randomized controlled … Arterial hypertension, obesity and non-alcoholic fatty liver disease: is there any connection? Metabolically healthy obesity and the development of nonalcoholic fatty liver disease fatty liver and its fibrous changes found in simple obesity of children Drug-induced liver injury in obesity and nonalcoholic fatty liver disease Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index Evaluation and management of obesity-related nonalcoholic fatty liver disease Macronutrients and the adipose-liver axis in obesity and fatty liver obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease? Nonalcoholic fatty liver disease and obesity Early obesity: risk factor for fatty liver disease … complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome Nonalcoholic fatty liver disease and obesity Drinking and obesity: alcoholic liver disease/nonalcoholic fatty liver disease interactions Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease The intersection of nonalcoholic fatty liver disease and obesity Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity obesity-associated nonalcoholic fatty liver disease Nonalcoholic fatty liver disease, diabetes, obesity, and hepatocellular carcinoma Acetaminophen‐induced liver injury in
The role of insulin resistance in nonalcoholic fatty liver disease insulin resistance in nonalcoholic fatty liver disease Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance Association of nonalcoholic fatty liver disease with insulin resistance Modulation of insulin resistance in nonalcoholic fatty liver disease Nonalcoholic fatty liver disease and insulin resistance : new insights and potential new treatments Nonalcoholic fatty liver disease as a complication of insulin resistance The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review insulin resistance and the pathogenesis of nonalcoholic fatty liver disease Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? The fatty liver and insulin resistance insulin resistance , the metabolic syndrome, and nonalcoholic fatty liver disease insulin resistance in development and progression of nonalcoholic fatty liver disease Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease Nonalcoholic fatty liver disease, hepatic insulin resistance , and type 2 diabetes Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines fatty liver , insulin resistance , and dyslipidemia Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison? Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver insulin resistance across the spectrum of nonalcoholic fatty liver disease A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease insulin resistance , inflammation, and non-alcoholic fatty liver disease Mechanisms of insulin resistance in primary and secondary nonalcoholic fatty liver Pathogenesis of insulin resistance and atherogenic dyslipidemia in nonalcoholic fatty liver disease fatty liver —an additional and treatable feature of the insulin resistance syndrome Ectopic fat, insulin resistance , and nonalcoholic fatty liver disease: implications for cardiovascular disease Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance Non-alcoholic fatty liver and insulin resistance : a cause–effect relationship? Obesity, insulin resistance , and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease Non-alcoholic fatty liver disease in obese youth with insulin resistance and type 2 diabetes Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD) insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease Non-alcoholic fatty liver disease and insulin resistance : from bench to bedside Non-alcoholic fatty liver disease, insulin resistance , metabolic syndrome and their association with vascular risk Association of non-alcoholic fatty liver disease with metabolic
Beta oxidation of fatty acids fatty acid Beta-oxidation disorders: a brief review Mechanisms mediating the regulation of peroxisomal fatty acid Beta-oxidation by PPARα Inhibition of mitochondrial Beta-oxidation as a mechanism of hepatotoxicity Rat liver peroxisomes catalyze the Beta oxidation of fatty acids. Beta-oxidation of fatty acids: a century of discovery Beta-oxidation is essential for mouse oocyte developmental competence and early embryo development The enzymology of mitochondrial fatty acid Beta-oxidation and its application to follow-up analysis of positive neonatal screening results Dynamic simulations on the mitochondrial fatty acid Beta-oxidation network Beta-oxidation of unsaturated fatty acids: a revised pathway Functions and organization of peroxisomal Beta-oxidation Clinical and biological features at diagnosis in mitochondrial fatty acid Beta‐oxidation defects: a French pediatric study of 187 patients Beta (β)-oxidation of fatty Acid and its associated Disorders TFPa/HADHA is required for fatty acid Beta-oxidation and cardiolipin re-modeling in human cardiomyocytes Peroxisomal multifunctional Beta-oxidation protein of Saccharomyces cerevisiae. Molecular analysis of the fox2 gene and gene product. Hepatic mitochondrial Beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test Amiodarone inhibits the mitochondrial Beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid Beta-oxidation Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound Beta-oxidation enzyme of mitochondria Bezafibrate for an inborn mitochondrial Beta-oxidation defect Metabolic reprogramming from glycolysis to fatty acid uptake and Beta-oxidation in platinum-resistant cancer cells Production of lactones and peroxisomal Beta-oxidation in yeasts Novel fatty acid Beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial Beta-oxidation of fatty acids. oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid Beta-oxidation in rats fed a methionine-choline deficient diet Hepatic steatosis and peroxisomal fatty acid Beta-oxidation SIRT6 promotes hepatic Beta-oxidation via activation of PPARα Assessment of fatty acid Beta oxidation in cells and isolated mitochondria Human trifunctional protein alpha links cardiolipin remodeling to Beta-oxidation Increased Beta-oxidation and Improved Oocyte Developmental Competence in Response to l-Carnitine During Ovarian In Vitro Follicle Development in Mice Inducible Beta-oxidation pathway in Neurospora crassa Peroxisomal Beta-oxidation Studies on the Beta-oxidation of valproic acid in rat liver mitochondrial preparations. A systematic optimization of medium chain fatty acid biosynthesis via the reverse Beta-oxidation cycle in Escherichia coli Beta oxidation defects: biochemistry and clinical Comparative importance of fatty acid Beta-oxidation to nuclear maturation, gene expression, and glucose metabolism in mouse, bovine, and porcine cumulus oocyte … The fatty acid Beta-oxidation pathway is important for decidualization of endometrial stromal cells in both humans and mice A novel mechanism of monoethylhexyl phthalate in lipid accumulation via inhibiting fatty acid Beta-oxidation on hepatic cells Bergamot polyphenol extract reduces hepatocyte neutral fat by increasing Beta-oxidation A whole body, in vivo, fatty acid balance method to quantify PUFA metabolism (desaturation, elongation and Beta-oxidation) Beta-oxidation of polyunsaturated fatty acids by rat liver peroxisomes. A role for 2, 4-dienoyl-coenzyme A reductase in peroxisomal Beta-oxidation. Association of glyoxylate and Beta-oxidation enzymes with peroxisomes of
CD36 and macrophages in atherosclerosis CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism CD36: a critical anti-angiogenic receptor Hepatic fatty acid transporter CD36 is a common target of LXR, PXR, and PPARγ in promoting steatosis CD36 is a receptor for oxidized low density lipoprotein CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice CD36 is a sensor of diacylglycerides Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36 A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic … Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β … Scavenger receptors class AI/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in … A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice Expression cloning of SR-BI, a CD36-related class B scavenger receptor. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation Malaria susceptibility and CD36 mutation Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36 A CD36-dependent signaling cascade is necessary for macrophage foam cell formation Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL Identification of CD36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats … membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines: evidence implicating the lipid moiety of the lipoprotein as the … Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria CD36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. Plasmodium falciparum erythrocyte membrane protein 1 is